Welcome to kongre.net
Speaker
Chief Scientific Officer, Remix Therapeutics
Dominic Reynolds, Chief Scientific Officer at Remix Therapeutics, is speaking at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Workshop A: Identifying Functional RNA Targets at Scale to Prioritize Therapeutically Relevant Discovery Hypothesis”.
10–12 Nov 2026Boston, United States of America
Associate Director, Early Discovery Chemistry, PTC Therapeutics
Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder
Chief Scientific Officer, Dewpoint Therapeutics
Head of Cancer Biology, EPICS Therapeutics
Senior Principal Scientist & Research Fellow, Pfizer
Head of Small Molecules Medicinal Chemistry, Sanofi
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Dominic Reynolds, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].